Shanghai (1)

Valencia (1)

APL (2)

Active, not recruiting (1)

Recruiting (1)

phase 2 (1)

phase 4 (1)

PETHEMA Foundation (1)

Shanghai Jiao Tong University School of Medicine (1)

Shanghai Clinical Research Center (1)

atra (1)

chidamide+venetoclax (1)

idarubicin (1)

methotrexate (1)

drug (2)

Other (2)

Interventional (2)

APL

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

May 30, 2023

Recruiting

Mar 22, 2021